These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2469327)

  • 21. [Addition of HPA 23 to cyclosporin in the treatment of thrombopenic purpura in HIV-positive subjects].
    Laporte JP; Meyohas MC; Eliaszewicz M; Najman A; Frottier J; Woehrle R
    Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):870-2. PubMed ID: 2443894
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Experimental chemotherapy of AIDS].
    Rada B
    Cas Lek Cesk; 1988 May; 127(22):677-83. PubMed ID: 3293790
    [No Abstract]   [Full Text] [Related]  

  • 23. AIDS: the virus, antivirals and vaccines.
    Weber J
    Br J Hosp Med; 1987 Feb; 37(2):135-7, 140-1. PubMed ID: 2950962
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential inhibition of various mammalian DNA polymerase activities by ammonium 21-tungsto-9-antimoniate (HPA23).
    Ono K; Nakane H; Barré-Sinoussi F; Chermann JC
    Eur J Biochem; 1988 Sep; 176(2):305-10. PubMed ID: 2458259
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lack of HPA-23 antiviral activity in HIV-infected patients without AIDS.
    Burgard M; Sansonetti P; Vittecoq D; Descamps P; Guetard D; Herson S; Rozenbaum W; Rouzioux C
    AIDS; 1989 Oct; 3(10):665-8. PubMed ID: 2480798
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reverse transcriptase activity in a case of ovine lymphoblastic leukaemia.
    Tomley FM; Armstrong SJ; Owen LN
    Res Vet Sci; 1983 Jan; 34(1):50-4. PubMed ID: 6188194
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biological and biochemical anti-human immunodeficiency virus activity of UC 38, a new non-nucleoside reverse transcriptase inhibitor.
    McMahon JB; Buckheit RW; Gulakowski RJ; Currens MJ; Vistica DT; Shoemaker RH; Stinson SF; Russell JD; Bader JP; Narayanan VL; Schultz RJ; Brouwer WG; Felauer EE; Boyd MR
    J Pharmacol Exp Ther; 1996 Jan; 276(1):298-305. PubMed ID: 8558446
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In search of specific inhibitors of retrovirus replication.
    De Clercq E; Balzarini J
    Antiviral Res; 1985; Suppl 1():89-94. PubMed ID: 2417552
    [No Abstract]   [Full Text] [Related]  

  • 29. Spectrum of antiviral activity and mechanism of action of zidovudine. An overview.
    Furman PA; Barry DW
    Am J Med; 1988 Aug; 85(2A):176-81. PubMed ID: 3044082
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of RNA-dependent DNA polymerase of murine oncornaviruses by ammonium-5-tungsto-2-antimoniate.
    Chermann JC; Sinoussi FC; Jasmin C
    Biochem Biophys Res Commun; 1975 Aug; 65(4):1229-36. PubMed ID: 79415
    [No Abstract]   [Full Text] [Related]  

  • 31. Differential inhibitory effects of several pyrimidine 2',3'-dideoxynucleoside 5'-triphosphates on the activities of reverse transcriptase and various cellular DNA polymerases.
    Ono K; Nakane H; Herdewijn P; Balzarini J; De Clercq E
    Mol Pharmacol; 1989 May; 35(5):578-83. PubMed ID: 2471054
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Screening anti-HIV Chinese materia medica with HIV and equine infectious anemic virus reverse transcriptase.
    Tang X; Chen H; Zhang X; Quan K; Sun M
    J Tradit Chin Med; 1994 Mar; 14(1):10-3. PubMed ID: 7515133
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prospects of therapy for infections with human T-lymphotropic virus type III.
    Hirsch MS; Kaplan JC
    Ann Intern Med; 1985 Nov; 103(5):750-5. PubMed ID: 2413793
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of antiviral agents for the treatment of human immunodeficiency virus infection.
    Tartaglione TA; Collier AC
    Clin Pharm; 1987 Dec; 6(12):927-40. PubMed ID: 3322638
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reverse transcriptase activity of hepatitis B virus (HBV) DNA polymerase within core capsid: interaction with deoxynucleoside triphosphates and anti-HBV L-deoxynucleoside analog triphosphates.
    Lam W; Li Y; Liou JY; Dutschman GE; Cheng YC
    Mol Pharmacol; 2004 Feb; 65(2):400-6. PubMed ID: 14742682
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alpha, beta- and beta, gamma-methylene 5'-phosphonate derivatives of 3'-azido-2',3'-dideoxythymidine-5'-triphosphate. Correlation between affinity for reverse transcriptase, susceptibility to hydrolysis by phosphodiesterases and anti-retrovirus activity.
    Balzarini J; Herdewijn P; Pauwels R; Broder S; De Clercq E
    Biochem Pharmacol; 1988 Jun; 37(12):2395-403. PubMed ID: 2455521
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Studies on the mechanism of action of ammonium-5-tungsto-2-antimoniate (HPA 23).
    Raybaud N; Chermann JC; Sinoussi FC; Augery Y; Jasmin C
    Bibl Haematol; 1975 Oct; (43):504-7. PubMed ID: 61002
    [No Abstract]   [Full Text] [Related]  

  • 38. Phosphatidylazidothymidine. Mechanism of antiretroviral action in CEM cells.
    Hostetler KY; Carson DA; Richman DD
    J Biol Chem; 1991 Jun; 266(18):11714-7. PubMed ID: 1711037
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of the wheat germ DNA polymerase A activity by the antiviral drug HPA-23.
    Aoyama H; Jucá MB; Castroviejo M; Litvak S
    Plant Mol Biol; 1993 Dec; 23(5):1055-60. PubMed ID: 8260625
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of human immunodeficiency virus type I reverse transcriptase by suramin-related compounds.
    Jentsch KD; Hunsmann G; Hartmann H; Nickel P
    J Gen Virol; 1987 Aug; 68 ( Pt 8)():2183-92. PubMed ID: 2440983
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.